Edition:
United Kingdom

Transgene SA (TRNG.PA)

TRNG.PA on Paris Stock Exchange

2.97EUR
19 Oct 2018
Change (% chg)

€0.05 (+1.71%)
Prev Close
€2.92
Open
€2.93
Day's High
€3.01
Day's Low
€2.93
Volume
82,918
Avg. Vol
50,612
52-wk High
€3.60
52-wk Low
€2.40

Chart for

About

Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases. These products use viral vectors to directly or indirectly destroy diseased cells. The Company has approximately three products in clinical development: two immunotherapy products for... (more)

Overall

Beta: -0.15
Market Cap(Mil.): €186.79
Shares Outstanding(Mil.): 56.43
Dividend: --
Yield (%): --

Financials

  TRNG.PA Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -0.50 -- --
ROI: -39.20 0.21 14.27
ROE: -143.68 1.17 15.99

BRIEF-Transgene Q1 Operating Revenue Stable At 1.8 Million Euros

* TRANSGENE: €35.6 MILLION IN CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2018

26 Apr 2018

Earnings vs. Estimates